Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.
Business Model:
Revenue: $0
Employees: 11-50
Address: 111 pine street
City: san francisco
State: CA
Zip: 94111
Country: US
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena&s;s approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders. The company implements innovation in the field of regenerative medicine. Their science combines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Series A | 2 | $21M |
DEFTA Partners Rejuveron Life Sciences DEFTA Partners Rejuveron Life Sciences |
1/2021 | Series A | 2 | $8M |
DEFTA Partners Rejuveron Life Sciences DEFTA Partners Rejuveron Life Sciences |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|